Age-stratified analysis of euploidy rates in Progestin-Primed Ovarian Stimulation (PPOS) utilizing micronized progesterone or dydrogesterone versus GnRH analogues

采用微粒化孕酮或地屈孕酮与 GnRH 类似物进行孕激素预处理卵巢刺激 (PPOS) 的整倍体率年龄分层分析

阅读:1

Abstract

PURPOSES: This study aims to analyze the euploidy rates of PPOS utilizing micronized progesterone and dydrogesterone in comparison to conventional controlled ovarian stimulation (COS) protocols in pre-implantation genetic testing for aneuploidy (PGT-A) cycles stratified by age cohorts. METHODS: This was a retrospective study including 2897 PGT-A cycles from a single reproductive medicine center. Study groups were categorized by different COS protocols, including PPOS (micronized progesterone), PPOS (dydrogesterone), GnRH-agonist, or GnRH-antagonist, and further sub-grouped into < 35 years, 35-37 years, 38-40 years, and > 40 years. Data about baseline characteristics, protocols and embryonic outcomes were analyzed. Multivariate regression analysis and adjustment by inverse probability of treatment weighting (IPTW) were performed to investigate the correlation between COS protocols and euploidy rate per biopsied blastocyst. RESULTS: Before stratified analysis and adjustment, the PPOS (dydrogesterone) group had significantly higher age, lower AMH level and fewer AFC than the PPOS (micronized progesterone), the GnRH-a and GnRH-Ant groups. Euploidy rate per COC, per MII oocyte and per biopsied blastocyst were lowest in the PPOS (dydrogesterone) group, followed by the PPOS (micronized progesterone) group. In subgroup analysis, the euploidy rate showed great disparity in different age groups and declined sharply every three years. All COS protocols were statistically comparable with respect to euploidy rate across all age cohorts. Regression analysis and IPTW adjustment revealed age as the sole factor affecting euploidy rates, with ovarian stimulation protocols showing no association. CONCLUSIONS: PPOS protocols using micronized progesterone or dydrogesterone were statistically comparable with conventional COS regimens in euploidy rates across all different age groups. Considering the significant impact of age, the necessity of refined age stratification for a more rigorous discussion about the aneuploidy risk of different COS protocols was emphasized.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。